Published in Am J Cardiol on August 01, 1996
Modifier genes for hypertrophic cardiomyopathy. Curr Opin Cardiol (2002) 1.47
Elevated plasma chymotrypsin-like protease (chymase) activity in women with preeclampsia. Hypertens Pregnancy (2010) 0.92
RAAS gene polymorphisms influence progression of pediatric hypertrophic cardiomyopathy. Hum Genet (2007) 0.92
Ten renin-angiotensin system-related gene polymorphisms in maximally treated Canadian Caucasian patients with heart failure. Br J Clin Pharmacol (2008) 0.89
Histologic characterization of hypertrophic cardiomyopathy with and without myofilament mutations. Am Heart J (2009) 0.83
Polymorphisms of matrix metalloproteinase-7 and chymase are associated with susceptibility to and progression of gastric cancer in Japan. J Gastroenterol (2008) 0.83
Generation of a new congenic mouse strain with enhanced chymase expression in mast cells. PLoS One (2013) 0.83
Impact of angiotensin I converting enzyme insertion/deletion polymorphisms on dilated cardiomyopathy and hypertrophic cardiomyopathy risk. PLoS One (2013) 0.78
Role of renin-angiotensin system in gastric oncogenesis. J Gastroenterol Hepatol (2012) 0.77
The influence of Angiotensin converting enzyme and angiotensinogen gene polymorphisms on hypertrophic cardiomyopathy. PLoS One (2013) 0.76
Progression of Left Ventricular Dysfunction and Remodelling under Optimal Medical Therapy in CHF Patients: Role of Individual Genetic Background. Cardiol Res Pract (2011) 0.75
Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science (2001) 8.53
Atrial natriuretic factor--a circulating hormone stimulated by volume loading. Nature (1985) 4.23
The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J (2003) 4.09
Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation (1998) 3.99
Relationship between nonphenacetin combined analgesics and nephropathy: a review. Ad Hoc Committee of the International Study Group on Analgesics and Nephropathy. Kidney Int (2000) 3.86
Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest (1999) 3.28
Comparative nephrotoxicities of netilmicin and gentamicin in rats. Antimicrob Agents Chemother (1976) 2.98
Renal parenchymal accumulation of aminoglycoside antibiotics in rats. J Infect Dis (1974) 2.93
The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Eur Heart J (2003) 2.78
Mice with disrupted BK channel beta1 subunit gene feature abnormal Ca(2+) spark/STOC coupling and elevated blood pressure. Circ Res (2000) 2.76
Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet (2002) 2.61
AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor. Circulation (2000) 2.57
Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension (1986) 2.51
Multiplex real-time PCR and blood culture for identification of bloodstream pathogens in patients with suspected sepsis. Clin Microbiol Infect (2009) 2.28
Cardiopulmonary auscultation: duo for strings--Opus 99. Arch Intern Med (1999) 2.26
Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis (1996) 2.22
Posterior fossa neurovascular anomalies in essential hypertension. Lancet (1994) 2.22
Quantitative analysis of survival motor neuron copies: identification of subtle SMN1 mutations in patients with spinal muscular atrophy, genotype-phenotype correlation, and implications for genetic counseling. Am J Hum Genet (1999) 2.21
Experimental aminoglycoside nephrotoxicity. J Lab Clin Med (1975) 2.19
Cardiovascular and humoral responses to extremes of sodium intake in normal black and white men. Circulation (1979) 2.15
p53 regulates mitochondrial membrane potential through reactive oxygen species and induces cytochrome c-independent apoptosis blocked by Bcl-2. EMBO J (1999) 2.14
NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats. Hypertension (2000) 2.06
Hypothesis: Beta-adrenergic receptor blockers and weight gain: A systematic analysis. Hypertension (2001) 2.04
Substitution of conventional cyclosporin with a new microemulsion formulation in renal transplant patients: results after 1 year. Nephrol Dial Transplant (1996) 2.01
Regulation of calcium sparks and spontaneous transient outward currents by RyR3 in arterial vascular smooth muscle cells. Circ Res (2001) 1.88
Effects of multidisciplinary case management in patients with chronic renal insufficiency. Am J Med (1998) 1.86
Diagnosis of iron deficiency anemia in renal failure patients during the post-erythropoietin era. Am J Kidney Dis (1995) 1.85
Comparative nephrotoxicity of aminoglycoside antibiotics in rats. J Infect Dis (1978) 1.83
[An assembly hypothesis of chromosome movement and the changes of the spindle length during anaphase I in spermatocytes of Pales ferruginea]. Chromosoma (1972) 1.80
Signaling pathways in reactive oxygen species-induced cardiomyocyte apoptosis. Circulation (1999) 1.74
Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation. Circulation (2000) 1.74
Percutaneous treatment of pseudoaneurysms and arteriovenous fistulas after invasive vascular procedures. Catheter Cardiovasc Interv (1999) 1.73
Enzymuria in gentamicin-induced kidney damage. Antimicrob Agents Chemother (1975) 1.72
Ignition of calcium sparks in arterial and cardiac muscle through caveolae. Circ Res (2000) 1.71
The application of methods of non-linear dynamics for the improved and predictive recognition of patients threatened by sudden cardiac death. Cardiovasc Res (1996) 1.65
Isolation of a complex between the P protein of phage lambda and the dnaB protein of Escherichia coli. Eur J Biochem (1980) 1.61
Overnight urine collections to estimate sodium intake. Hypertension (1983) 1.58
A novel isoform of the smooth muscle cell differentiation marker smoothelin. J Mol Med (Berl) (1999) 1.53
Twin zygosity. Automated determination with microsatellites. J Reprod Med (1997) 1.53
A polymorphism in the endothelin-A receptor gene predicts survival in patients with idiopathic dilated cardiomyopathy. Eur Heart J (2001) 1.53
Tissue renin-angiotensin systems: new insights from experimental animal models in hypertension research. J Mol Med (Berl) (2001) 1.51
Homozygosity mapping of a gene locus for primary ciliary dyskinesia on chromosome 5p and identification of the heavy dynein chain DNAH5 as a candidate gene. Am J Respir Cell Mol Biol (2000) 1.50
Ostial renal artery stent placement for atherosclerotic renal artery stenosis in patients with coronary artery disease. Cathet Cardiovasc Diagn (1998) 1.50
Time for action. Arch Intern Med (1991) 1.48
Elective stenting of carotid artery stenosis in patients with severe coronary artery disease. Eur Heart J (1998) 1.48
Dysbiosis and pouchitis. Br J Surg (2006) 1.46
Nephrotoxicity of cephalosporin-gentamicin combinations in rats. Antimicrob Agents Chemother (1976) 1.45
ACE inhibition improves vagal reactivity in patients with heart failure. Am Heart J (1990) 1.45
Nontraumatic bilateral rupture of patellar tendons in a diabetic dialysis patient with secondary hyperparathyroidism. Nephrol Dial Transplant (1997) 1.45
Substituted 3-(phenylsulfonyl)-1-phenylimidazolidine-2,4-dione derivatives as novel nonpeptide inhibitors of human heart chymase. J Med Chem (1997) 1.45
A region on chromosome 3 is linked to dizygotic twinning. Nat Genet (2000) 1.44
Temperature-sensitive initiation of DNA replication in a mutant of Escherichia coli K12. Mol Gen Genet (1971) 1.44
[Cardiac manifestations of muscular dystrophies]. Z Kardiol (2005) 1.42
Systematic characterisation of disease associated balanced chromosome rearrangements by FISH: cytogenetically and genetically anchored YACs identify microdeletions and candidate regions for mental retardation genes. J Med Genet (1999) 1.41
Comparison of captopril with enalapril in the treatment of heart failure: influence on hemodynamics and measures of renal function. Cardiovasc Drugs Ther (1992) 1.39
Kidneys from pediatric donors: risk versus benefit. Clin Nephrol (1994) 1.39
Baroreceptor-mediated release of vasopressin in patients with chronic congestive heart failure and defective sympathetic responsiveness. Am J Cardiol (1992) 1.39
Molecular analysis of pericentrin gene (PCNT) in a series of 24 Seckel/microcephalic osteodysplastic primordial dwarfism type II (MOPD II) families. J Med Genet (2009) 1.38
A left-to-left shunt. Am J Med (1999) 1.38
STOPPING at the CAPPP of good HOPE. Nephrol Dial Transplant (2000) 1.38
Racial differences in blood pressure in Evans County, Georgia: relationship to sodium and potassium intake and plasma renin activity. J Chronic Dis (1980) 1.38
Release of endogenous catecholamines in the ischemic myocardium of the rat. Part A: Locally mediated release. Circ Res (1984) 1.38
Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappaB and induces tissue factor and PAI-1 expression: a potential link to accelerated arteriosclerosis. Circulation (1999) 1.37
Effects of volume expansion and contraction in normotensive whites, blacks, and subjects of different ages. Circulation (1979) 1.36
Novel splice donor site mutation in the cardiac myosin-binding protein-C gene in familial hypertrophic cardiomyopathy. Characterization Of cardiac transcript and protein. J Clin Invest (1997) 1.36
Long term effect of cis-diamminedichloride platinum (CDDP) on renal function and structure in man. Cancer (1978) 1.35
A DNA primase specified by I-like plasmids. Proc Natl Acad Sci U S A (1979) 1.35
A modified quantitative subjective global assessment of nutrition for dialysis patients. Nephrol Dial Transplant (1999) 1.35
Effects of intracellular angiotensin II in vascular smooth muscle cells. Circ Res (1996) 1.34
Interleukin-8 delays spontaneous and tumor necrosis factor-alpha-mediated apoptosis of human neutrophils. Kidney Int (1998) 1.34
Precursor of C4 antisense RNA of bacteriophages P1 and P7 is a substrate for RNase P of Escherichia coli. Proc Natl Acad Sci U S A (1995) 1.33
An intestinal fistula in a 3-year-old child caused by the ingestion of magnets: report of a case. Surg Today (1995) 1.33
Differential effect of hydrogen peroxide and superoxide anion on apoptosis and proliferation of vascular smooth muscle cells. Circulation (1997) 1.32
Higher oxidation states of prostaglandin H synthase. EPR study of a transient tyrosyl radical in the enzyme during the peroxidase reaction. Eur J Biochem (1988) 1.31
Monocyte infiltration and adhesion molecules in a rat model of high human renin hypertension. Hypertension (1999) 1.30
Correlates of health care satisfaction in inner-city patients with hypertension and chronic renal insufficiency. Soc Sci Med (1995) 1.29
Localization of thiazide-sensitive Na(+)-Cl(-) cotransport and associated gene products in mouse DCT. Am J Physiol Renal Physiol (2001) 1.29
KCNQ4: a gene for age-related hearing impairment? Hum Mutat (2006) 1.29
Aster-free spindle poles in insect spermatocytes: evidence for chromosome-induced spindle formation? J Cell Biol (1986) 1.28
[Structure and function of the spindle apparatus]. Naturwissenschaften (1969) 1.26
The tripartite immunity system of phages P1 and P7. FEMS Microbiol Rev (1995) 1.25
[Guidelines for therapy of chronic heart failure]. Z Kardiol (2005) 1.24
A neuronal nitric oxide synthase (NOS-I) haplotype associated with schizophrenia modifies prefrontal cortex function. Mol Psychiatry (2006) 1.24
Endothelial dysfunction and salt-sensitive hypertension in spontaneously diabetic Goto-Kakizaki rats. Hypertension (2001) 1.23
Replication of bacteriophages in Escherichia coli mutants thermosensitive in DNA synthesis. Mol Gen Genet (1970) 1.22
Severe autosomal dominant hypertension and brachydactyly in a unique Turkish kindred maps to human chromosome 12. Nat Genet (1996) 1.22
Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy. Lancet (1998) 1.22